首页> 美国卫生研究院文献>other >Regulated delayed synthesis of lipopolysaccharide and enterobacterial common antigen of Salmonella Typhimurium enhances immunogenicity and cross-protective efficacy against heterologous Salmonella challenge
【2h】

Regulated delayed synthesis of lipopolysaccharide and enterobacterial common antigen of Salmonella Typhimurium enhances immunogenicity and cross-protective efficacy against heterologous Salmonella challenge

机译:鼠伤寒沙门氏菌的脂多糖和肠细菌共同抗原的调控延迟合成增强了针对异源沙门氏菌攻击的免疫原性和交叉保护功效

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Lipopolysaccharide (LPS) O-antigen and enterobacterial common antigen (ECA) are two major polysaccharide structures on the surface of Salmonella enterica serovar Typhimurium. Previous studies have demonstrated that regulated truncation of LPS enhances the cross-reaction against conserved outer membrane proteins (OMPs) from enteric bacteria. We speculate that the regulation of both O-antigen and ECA may enhance the induction of immune responses against conserved OMPs from enteric bacteria. In this work we targeted rfbB and rffG genes which encode dTDP-glucose 4,6-dehydratases and share the same function in regulating O-antigen and ECA synthesis. We constructed a mutant, S496 (ΔrfbB6 ΔrffG7 ΔpagL73::TT araC PBAD rfbB-3), in which rfbB gene expression was dependent on exogenously supplied arabinose during in vitro growth and achieved the simultaneous tight regulation of both LPS and ECA synthesis, as demonstrated by the LPS profile and Western blotting using antisera against LPS and ECA. When administered orally, S. Typhimurium S496 was completely attenuated for virulence but still retained the capacity to colonize and disseminate in mice. In addition, we found that oral immunization with S496 resulted in increased immune responses against OMPs from enteric bacteria and enhanced survival compared with immunization with S492 possessing ΔrfbB6 ΔrffG8 mutations when challenged with lethal doses of Salmonella Choleraesuis or Salmonella Enteritidis. These results indicate that S. Typhimurium arabinose-regulated rfbB strain S496 is a good vaccine candidate, conferring cross-protection against lethal challenge with heterologous Salmonella.
机译:脂多糖(LPS)O抗原和肠细菌共同抗原(ECA)是肠沙门氏菌血清鼠伤寒沙门氏菌表面的两个主要多糖结构。先前的研究表明,LPS的截短可增强与肠道细菌保守的外膜蛋白(OMP)的交叉反应。我们推测O抗原和ECA的调节可能会增强针对肠道细菌保守OMPs的免疫反应的诱导。在这项工作中,我们针对的是编码dTDP-葡萄糖4,6-脱水酶的rfbB和rffG基因,它们在调节O抗原和ECA合成中具有相同的功能。我们构建了一个突变体S496(ΔrfbB6ΔrffG7ΔpagL73:: TT araC PBAD rfbB-3),其中rfbB基因的表达依赖于体外生长过程中外源提供的阿拉伯糖,并同时实现了LPS和ECA合成的同时严格调控。通过LPS图谱和使用针对LPS和ECA的抗血清进行蛋白质印迹分析。口服时,鼠伤寒沙门氏菌S496的毒力完全减弱,但仍保留在小鼠中定居和传播的能力。此外,我们发现,用致命剂量的沙门氏菌霍乱沙门氏菌或肠炎沙门氏菌攻击时,用具有ΔrfbB6ΔrffG8突变的S492免疫相比,用S496口服免疫可提高针对肠道细菌OMPs的免疫反应并提高存活率。这些结果表明,鼠伤寒沙门氏菌阿拉伯糖调节的 rfbB 菌株S496是很好的候选疫苗,可以交叉抵抗异源沙门氏菌的致死性攻击。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号